Organigram Inc., which was discovered selling products containing a banned pesticide announces that Greg Engel has been appointed CEO, taking over from Denis Arsenault.
Mr. Arsenault, who ran the company for the past three years, is moving to the board of directors as executive chairman, Moncton-based Organigram said in a press release issued before markets opened.
The management shuffle comes just two days after Organigram announced the results of an internal investigation into a recall announced two months ago after myclobutanil was discovered in medicine sold to patients.
The company said its investigation turned up “inconclusive findings” with “no hard evidence leading to the source of the contamination.”
The inability to pinpoint the problem, and the continuing worries over banned chemicals in the sector, have cast doubt on the credibility of the new industry, which is licensed by the federal government to produce safe, pharmaceutical products for patients who use the drug to treat everything from cancer-related pain to epilepsy.
For the full story go to The Globe and Mail
Read More